Vanda Pharmaceuticals Inc.
A Washington, D.C.-based biopharmaceutical company that develops medicines for brain and nervous-system conditions. Its products include Hetlioz, a treatment for a rare sleep disorder in which totally blind people's internal body clocks drift because they cannot perceive light, and Fanapt, an antipsychotic for schizophrenia. Founded in 2003 by a Greek-American scientist who worked on the Human Genome Project, the company takes its name from the Vanda, a genus of orchids.
Sold 553.5K
Bought 437.2K
Sold 1.72M
Sold 715.7K
Sold 1.67M
Bought 162.0K
Sold 745.5K
Bought 2.57M · Sold 950.0K
Granted 4.82M · Bought 470.0K · Sold 2.27M
Sold 12.9K
Sold 12.9K
Sold 12.9K
Sold 12.9K
Sold 12.9K
Sold 12.9K
Sold 3.61M
Sold 3.61M
Granted 564.4K · Sold 170.1K
Granted 497.9K · Bought 2.0K · Sold 122.4K
Granted 563.1K · Sold 158.7K
Granted 433.9K · Sold 84.9K
Granted 261.2K · Sold 42.2K
Granted 277.5K · Bought 5.0K · Sold 101.5K
Granted 445.6K · Bought 50.0K · Sold 277.3K
Granted 130.0K · Sold 4.6K
Granted 167.0K · Sold 2.1K
Granted 160.7K
Granted 165.1K · Sold 30.0K
Granted 100.0K · Sold 24.9K
Granted 183.8K · Sold 45.3K
Granted 98.7K
Granted 105.4K · Sold 83.4K
Granted 120.0K · Sold 56.9K
Granted 82.5K · Sold 37.6K
Granted 122.5K · Sold 107.5K
Sold 12.9K
Granted 15.0K
Granted 73.9K · Sold 67.0K
Granted 10.0K
Granted 80.0K
Granted 5.0K
Granted 40.0K · Sold 37.6K
Granted 46.3K · Sold 46.3K
Granted 4.7K · Sold 4.7K
Granted 3.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kairouz Habib +9 co-filers10% owner · 8 transactions | — | 8.57Mas of Nov 2006 | — | — | 553.5K |
| Deerfield Management Co +5 co-filersReporting owner · 9 transactions | — | 6.00Mas of Dec 2015 | — | 437.2K | — |
| Care Capital II LLC +3 co-filers10% owner · 18 transactions | — | 4.84Mas of Dec 2006 | — | — | 1.72M |
| Bio One Capital Pte Ltd. +2 co-filers10% owner · 9 transactions | — | 4.43Mas of Nov 2006 | — | — | 715.7K |
| Deerfield Management Co +5 co-filersReporting owner · 15 transactions | — | 4.33Mas of Sep 2016 | — | — | 1.67M |
| Deerfield Management Co +4 co-filersReporting owner · 12 transactions | — | 4.14Mas of Dec 2014 | — | 162.0K | — |
| Barkas Alexander E +5 co-filers10% owner · 4 transactions | — | 3.88Mas of Nov 2006 | — | — | — |
| Tananbaum James BDirector · 9 transactions | — | 3.14Mas of Dec 2006 | — | — | 745.5K |
| Tang Capital Management LLC +2 co-filers10% owner · 15 transactions | — | 2.72Mas of Jan 2010 | — | 2.57M | 950.0K |
| Polymeropoulos Mihael HristosPresident and CEO, Director, Chairman of the Board · 224 transactions | — | 2.70M | 4.82M | 470.0K | 2.27M |
| Blair James C10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| Dovey Brian H10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| More Robert J10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| Schoemaker Kathleen K10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| Treu Jesse I10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| Vitullo Nicole10% owner · 7 transactions | — | 2.00Mas of Dec 2006 | — | — | 12.9K |
| Domain Partners VI, L.P.10% owner · 3 transactions | — | 1.95Mas of Dec 2006 | — | — | — |
| Karabelas Argeris NDirector · 34 transactions | — | 1.95Mas of Mar 2010 | — | — | 3.61M |
| Ramsay David RussFormer Director · 34 transactions | — | 1.95Mas of Mar 2010 | — | — | 3.61M |
| Hockmeyer Wayne TDirector · 1 transaction | — | 1.60Mas of Apr 2006 | — | — | — |
| Medimmune Inc /De10% owner · 1 transaction | — | 1.60Mas of Apr 2006 | — | — | — |
| Birznieks GuntherSVP, Business Development · 30 transactions | — | 494.2K | 564.4K | — | 170.1K |
| Moran Kevin PatrickSVP, CFO & Treasurer · 26 transactions | — | 412.6K | 497.9K | 2.0K | 122.4K |
| Williams TimothySVP & General Counsel · 29 transactions | — | 377.4K | 563.1K | — | 158.7K |
| Wijkstrom JoakimSVP, Chief Marketing Officer · 20 transactions | — | 333.5K | 433.9K | — | 84.9K |
| Dugan Richard WDirector · 21 transactions | — | 219.1K | 261.2K | — | 42.2K |
| Kelly James PatrickEVP & Chief Financial Officer · 43 transactions | — | 186.9Kas of Mar 2020 | 277.5K | 5.0K | 101.5K |
| Clark William DSr. VP, Chief Business Officer · 88 transactions | — | 168.3Kas of Feb 2010 | 445.6K | 50.0K | 277.3K |
| Reverberi Gian PieroSVP & Chief Commercial Officer · 13 transactions | — | 165.4Kas of Mar 2020 | 130.0K | — | 4.6K |
| Chrousos PhaedraDirector · 9 transactions | — | 164.9K | 167.0K | — | 2.1K |
| Ward Anne SempowskiDirector · 7 transactions | — | 160.7K | 160.7K | — | — |
| Honore TageDirector · 6 transactions | — | 135.1K | 165.1K | — | 30.0K |
| Gulino Richard L.SVP, General Counsel & Sec. · 9 transactions | — | 115.1Kas of Mar 2018 | 100.0K | — | 24.9K |
| Mitchell Stephen RayDirector · 17 transactions | — | 112.8K | 183.8K | — | 45.3K |
| Duncan Charles CliffDirector · 2 transactions | — | 98.7K | 98.7K | — | — |
| Jones Aranthan IIChief Corp. Affairs Officer · 13 transactions | — | 82.0Kas of Sep 2021 | 105.4K | — | 83.4K |
| Watkins ThomasDirector · 14 transactions | — | 69.5Kas of Jun 2022 | 120.0K | — | 56.9K |
| Baroldi PaoloSVP & Chief Medical Officer · 14 transactions | — | 58.2Kas of Jan 2017 | 82.5K | — | 37.6K |
| Repella RobertSVP & Chief Commercial Officer · 8 transactions | — | 44.5Kas of Nov 2013 | 122.5K | — | 107.5K |
| DP VI Associates, L.P.10% owner · 2 transactions | — | 21.1Kas of Dec 2006 | — | — | 12.9K |
| Cola Michael FDirector · 3 transactions | — | 15.0Kas of Jun 2019 | 15.0K | — | — |
| Feeney John JosephSVP & Chief Medical Officer · 23 transactions | — | 12.0Kas of Feb 2012 | 73.9K | — | 67.0K |
| Milano VincentDirector · 2 transactions | — | 10.0Kas of Jun 2018 | 10.0K | — | — |
| Halak Brian KDirector · 1 transaction | — | 7.3Kas of Mar 2010 | — | — | — |
| McGuire Daniel PatrickSVP, GC and Secretary · 1 transaction | — | 6.0K | 80.0K | — | — |
| Bate KennethDirector · 1 transaction | — | 5.0Kas of Jun 2017 | 5.0K | — | — |
| Irish Stephanie RastActing CFO/Treasurer · 5 transactions | — | 2.2Kas of Feb 2010 | 40.0K | — | 37.6K |
| Shallcross Steven ASr. VP, CFO, Treasurer · 40 transactions | — | 1.7Kas of Nov 2007 | 46.3K | — | 46.3K |
| Phadke Deepak ShripadVice President Manufacturing · 2 transactions | — | 0as of Dec 2006 | 4.7K | — | 4.7K |
| Gianchetti Albert W.Sr.VP,Chief Commercial Officer · 1 transaction | — | 0as of Oct 2007 | 3.0K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -13.75M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.